- Home
- MDXG vs NBXG Comparison
MDXG vs NBXG Comparison
Compare MDXG & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDXG | NBXG |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 530.2M | 1.0B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MDXG | NBXG |
|---|---|---|
| Price | $3.59 | $15.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 152.4K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $3.03 | $12.32 |
| 52 Week High | $7.99 | $15.87 |
Technical Indicators
Market Signals| Indicator | MDXG | NBXG |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 57.80 |
| Support Level | $3.11 | $15.09 |
| Resistance Level | $7.39 | $15.54 |
| Average True Range (ATR) | 0.16 | 0.25 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 79.43 | 53.85 |
Price Performance
Historical ComparisonAbout MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in NextGen Companies.